Race, scleroderma, and survival: Why is there a difference?

Journal of Rheumatology

Volumn 32, Issue 10, 2005, Pages 1873-1874

  Mayes, Maureen D ^a  

^a UNIVERSITY OF TEXAS MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AFRICAN AMERICAN; CAUCASIAN; CLINICAL FEATURE; COMORBIDITY; DEMOGRAPHY; DISEASE ACTIVITY; DISEASE SEVERITY; EDITORIAL; ETHNOLOGY; HUMAN; PRIORITY JOURNAL; PROGNOSIS; RACE; SCLERODERMA; SURVIVAL; SYSTEMIC SCLEROSIS; UNITED STATES;

AFRICAN AMERICANS; EUROPEAN CONTINENTAL ANCESTRY GROUP; GENETIC PREDISPOSITION TO DISEASE; HOSPITAL MORTALITY; HUMANS; PROGNOSIS; SCLERODERMA, SYSTEMIC; SURVIVAL RATE;

EID: 26444554001     PISSN: 0315162X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Editorial

References (11)

1. Reveille JD. Ethnicity and race and systemic sclerosis: how it affects susceptibility, severity, antibody genetics, and clinical manifestations. Curr Rheumatol Rep 2003;5:160-7.
2. Mayes MD, Lacey JV Jr, Beebe-Dimmer J, et al. Prevalence, incidence, survival, and disease characteristics of systemic sclerosis in a large US population. Arthritis Rheum 2003;48:2246-55.
3. Reveille JD, Fischbach M, McNearney T, et al. Systemic sclerosis in 3 US ethnic groups: a comparison of clinical, sociodemographic, serologic, and immungenetic determinants. Semin Arthritis Rheum 2001;30:332-46.
4. Kuwana M, Kaburaki J, Arnett FC, et al. Influence of ethnic background on clinical and serologic features in patients with systemic sclerosis and anti-DNA topoisomerase I antibody. Arthritis Rheum 1999;42:465-74.
5. Greidinger EL, Flaherty KT, White B, et al. African-American race and antibodies to topoisomerase I are associated with increased severity of scleroderma lung disease. Chest 1998;114:801-7.
6. Reveille JD, Durban E, Goldstein R, et al. Racial differences in the frequencies of scleroderma-related autoantibodies. Arthritis Rheum 1992;35:216-8.
7. Laing TJ, Gillespie BW, Toth MB, et al. Racial differences in scleroderma among women in Michigan. Arthritis Rheum 1997;40:734-42.
8. Medsger TA Jr, Masi AT, Rodnan GP, et al. Survival with systemic sclerosis (scleroderma): a life-table analysis of clinical and demographic factors in 309 patients. Ann Intern Med 1971;75:369-76.
9. Nietert PJ, Silver RM, Mitchell HC, et al. Demographic and clinical factors associated with in-hospital death among patients with systemic sclerosis. J Rheumatol 2005;32:1888-92.
10. Arnett FC, Howard RF, Tan F, et al. Increased prevalence of systemic sclerosis in a Native American tribe in Oklahoma. Association with an Amerindian HLA haplotype. Arthritis Rheum 1996;39:1362-70.
11. Hudson LL, Silver RM, Pandey JP. Ethnic differences in cytotoxic T lymphocyte associated antigen 4 genotype associations with systemic sclerosis. J Rheumatol 2004;31:85-7.